Effect of Steroids During Pneumocystis Infection Among Non HIV Immunocompromised Patients
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Hematologic Neoplasms
- Immunocompromised Patient
- Immunosuppressive Agents
- Neoplasms
- Pneumocystis
- Steroids
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT02944045
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Virginie Lemiale, MD APHP Study Director: Elie Azoulay, MD PHD APHP